• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌中的 E3 泛素连接酶及其治疗意义。

E3 ubiquitin ligases in nasopharyngeal carcinoma and implications for therapies.

机构信息

Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, 315040, China.

Department of Otolaryngology-Head and Neck Surgery, The Affiliated People's Hospital of Ningbo University, Ningbo, 315040, China.

出版信息

J Mol Med (Berl). 2023 Dec;101(12):1543-1565. doi: 10.1007/s00109-023-02376-7. Epub 2023 Oct 5.

DOI:10.1007/s00109-023-02376-7
PMID:37796337
Abstract

Nasopharyngeal carcinoma (NPC) is one of the most common squamous cell carcinomas of the head and neck, and Epstein-Barr virus (EBV) infection is one of the pathogenic factors involved in the oncogenetic development and progression of NPC. E3 ligases, which are key members of the ubiquitin proteasome system (UPS), specifically recognize various oncogenic factors and tumor suppressors and contribute to determining their fate through ubiquitination. Several studies have demonstrated that E3 ligases are aberrantly expressed and mutated in NPC and that these changes are closely associated with the occurrence and progression of NPC. Herein, we aim to thoroughly review the specific action mechanisms by which E3 ligases participate in NPC signaling pathways and discuss their functional relationship with EBV. Moreover, we describe the current progress in and limitations for targeted therapies against E3 ligases in NPC. KEY MESSAGES: • E3 ubiquitin ligases, as members of the UPS system, determine the fate of their substrates and may act either as oncogenic or anti-tumorigenic factors in NPC. • Mutations or dysregulated expression of E3 ubiquitin ligases is closely related to the occurrence, development, and therapeutic sensitivity of NPC, as they play important roles in several signaling pathways affected by EBV infection. • As promising therapeutic targets, E3 ligases may open new avenues for treatment and for improving the prognosis of NPC patients.

摘要

鼻咽癌(NPC)是头颈部最常见的鳞状细胞癌之一,EBV 感染是 NPC 癌基因发生和发展的致病因素之一。E3 连接酶是泛素蛋白酶体系统(UPS)的关键成员,特异性识别各种致癌因子和肿瘤抑制因子,并通过泛素化作用决定它们的命运。多项研究表明,E3 连接酶在 NPC 中表达异常和突变,这些变化与 NPC 的发生和发展密切相关。本文旨在全面综述 E3 连接酶参与 NPC 信号通路的具体作用机制,并探讨其与 EBV 的功能关系。此外,还描述了针对 NPC 中 E3 连接酶的靶向治疗的最新进展和局限性。关键信息:• E3 泛素连接酶作为 UPS 系统的成员,决定其底物的命运,在 NPC 中可能作为致癌或抑癌因子发挥作用。• E3 泛素连接酶的突变或表达失调与 NPC 的发生、发展和治疗敏感性密切相关,因为它们在 EBV 感染影响的几个信号通路中发挥重要作用。• 作为有前途的治疗靶点,E3 连接酶可能为 NPC 患者的治疗和改善预后开辟新途径。

相似文献

1
E3 ubiquitin ligases in nasopharyngeal carcinoma and implications for therapies.鼻咽癌中的 E3 泛素连接酶及其治疗意义。
J Mol Med (Berl). 2023 Dec;101(12):1543-1565. doi: 10.1007/s00109-023-02376-7. Epub 2023 Oct 5.
2
EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.EBV-miR-BART10-3p通过靶向BTRC促进上皮-间质转化并推动鼻咽癌转移。
Oncotarget. 2015 Dec 8;6(39):41766-82. doi: 10.18632/oncotarget.6155.
3
Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein-Barr Virus Infection.鼻咽癌进展:累积的基因组不稳定性和持续的 Epstein-Barr 病毒感染。
Curr Oncol. 2022 Aug 23;29(9):6035-6052. doi: 10.3390/curroncol29090475.
4
Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.关于 Epstein-Barr 病毒(EBV)相关的鼻咽癌:重点介绍 EBV 的潜伏基因产物。
Medicina (Kaunas). 2022 Dec 20;59(1):2. doi: 10.3390/medicina59010002.
5
Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma.鉴定出 EBV 相关鼻咽癌中存在的复发性 UBR5-ZNF423 融合基因。
J Pathol. 2013 Oct;231(2):158-67. doi: 10.1002/path.4240.
6
EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.鼻咽癌中的EB病毒感染与糖代谢
Adv Exp Med Biol. 2017;1018:75-90. doi: 10.1007/978-981-10-5765-6_6.
7
Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.通过全基因组测序鉴定鼻咽癌和鼻咽癌衍生的 Epstein-Barr 病毒中的基因组改变。
Carcinogenesis. 2018 Dec 31;39(12):1517-1528. doi: 10.1093/carcin/bgy108.
8
The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒感染在鼻咽癌发病机制中的作用。
Virol Sin. 2015 Apr;30(2):107-21. doi: 10.1007/s12250-015-3592-5. Epub 2015 Apr 21.
9
Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.循环 Epstein-Barr 病毒 DNA 分析在鼻咽癌管理中的临床应用
Chin Clin Oncol. 2016 Apr;5(2):18. doi: 10.21037/cco.2016.03.07.
10
Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.爱泼斯坦-巴尔病毒潜伏膜蛋白1(LMP1)和LMP2A对鼻咽癌细胞中DNA损伤信号传导及细胞死亡反应的调控
J Virol. 2015 Aug;89(15):7612-24. doi: 10.1128/JVI.00958-15. Epub 2015 May 13.

引用本文的文献

1
Roles of deubiquitinases in urologic cancers (Review).去泛素化酶在泌尿系统癌症中的作用(综述)
Oncol Lett. 2024 Oct 14;28(6):609. doi: 10.3892/ol.2024.14743. eCollection 2024 Dec.
2
Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients.基于 11 个 E3 相关基因的结肠癌患者预后模型的建立与验证。
Curr Pharm Des. 2024;30(12):935-951. doi: 10.2174/0113816128292398240306160051.

本文引用的文献

1
Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.环状 RNA circPVT1 通过β-TrCP/c-Myc/SRSF1 正反馈环促进鼻咽癌转移。
Mol Cancer. 2022 Oct 5;21(1):192. doi: 10.1186/s12943-022-01659-w.
2
RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma.RNF38 通过泛素化 ACTN4 抑制鼻咽癌的生长和转移。
BMC Cancer. 2022 May 15;22(1):549. doi: 10.1186/s12885-022-09641-x.
3
MFSD4A inhibits the malignant progression of nasopharyngeal carcinoma by targeting EPHA2.
MFSD4A 通过靶向 EPHA2 抑制鼻咽癌的恶性进展。
Cell Death Dis. 2022 Apr 11;13(4):332. doi: 10.1038/s41419-022-04793-x.
4
Targeted protein degradation: mechanisms, strategies and application.靶向蛋白降解:机制、策略与应用。
Signal Transduct Target Ther. 2022 Apr 4;7(1):113. doi: 10.1038/s41392-022-00966-4.
5
Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma.Cullin 4A/蛋白精氨酸甲基转移酶 5(CUL4A/PRMT5)促进鼻咽癌中的细胞恶性表型和肿瘤生长。
Bioengineered. 2022 Apr;13(4):8712-8723. doi: 10.1080/21655979.2022.2054756.
6
Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer.Skp2 稳定 Mcl-1 并赋予结直肠癌细胞放射抵抗性。
Cell Death Dis. 2022 Mar 18;13(3):249. doi: 10.1038/s41419-022-04685-0.
7
Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression.化学合成的华蟾毒精通过诱导ENKUR稳定p53表达来抑制鼻咽癌转移。
Cancer Lett. 2022 Apr 10;531:57-70. doi: 10.1016/j.canlet.2022.01.025. Epub 2022 Feb 1.
8
Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.沙利度胺预防鼻咽癌同步放化疗患者口腔黏膜炎的疗效和安全性:一项多中心、开放标签、随机对照试验。
Cancer. 2022 Apr 1;128(7):1467-1474. doi: 10.1002/cncr.34074. Epub 2021 Dec 15.
9
Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma.鼻咽癌的发病机制与精准医学进展
MedComm (2020). 2021 Jan 7;2(2):175-206. doi: 10.1002/mco2.32. eCollection 2021 Jun.
10
Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells.硼替佐米对蛋白酶体的抑制作用类似于减少头颈部癌细胞的生长,并增加肿瘤浸润免疫细胞。
Sci Rep. 2021 Sep 24;11(1):19051. doi: 10.1038/s41598-021-98450-6.